These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
230 related items for PubMed ID: 39125620
21. MicroRNA-140-5p targeting tumor necrosis factor-α prevents pulmonary arterial hypertension. Zhu TT, Zhang WF, Yin YL, Liu YH, Song P, Xu J, Zhang MX, Li P. J Cell Physiol; 2019 Jun; 234(6):9535-9550. PubMed ID: 30367500 [Abstract] [Full Text] [Related]
23. Resveratrol reverses monocrotaline-induced pulmonary vascular and cardiac dysfunction: a potential role for atrogin-1 in smooth muscle. Paffett ML, Lucas SN, Campen MJ. Vascul Pharmacol; 2012 Jun; 56(1-2):64-73. PubMed ID: 22146233 [Abstract] [Full Text] [Related]
30. Bioactive Compounds From Coptidis Rhizoma Alleviate Pulmonary Arterial Hypertension by Inhibiting Pulmonary Artery Smooth Muscle Cells' Proliferation and Migration. Luo S, Kan J, Zhang J, Ye P, Wang D, Jiang X, Li M, Zhu L, Gu Y. J Cardiovasc Pharmacol; 2021 Aug 01; 78(2):253-262. PubMed ID: 34554677 [Abstract] [Full Text] [Related]
31. Oxidized DNA Precursors Cleanup by NUDT1 Contributes to Vascular Remodeling in Pulmonary Arterial Hypertension. Vitry G, Paulin R, Grobs Y, Lampron MC, Shimauchi T, Lemay SE, Tremblay E, Habbout K, Awada C, Bourgeois A, Nadeau V, Paradis R, Breuils-Bonnet S, Roux-Dalvai F, Orcholski M, Potus F, Provencher S, Boucherat O, Bonnet S. Am J Respir Crit Care Med; 2021 Mar 01; 203(5):614-627. PubMed ID: 33021405 [Abstract] [Full Text] [Related]
33. DUSP5-mediated inhibition of smooth muscle cell proliferation suppresses pulmonary hypertension and right ventricular hypertrophy. Ferguson BS, Wennersten SA, Demos-Davies KM, Rubino M, Robinson EL, Cavasin MA, Stratton MS, Kidger AM, Hu T, Keyse SM, McKnight RA, Lane RH, Nozik ES, Weiser-Evans MCM, McKinsey TA. Am J Physiol Heart Circ Physiol; 2021 Aug 01; 321(2):H382-H389. PubMed ID: 34142888 [Abstract] [Full Text] [Related]
34. The HIF-1α/miR-26a-5p/PFKFB3/ULK1/2 axis regulates vascular remodeling in hypoxia-induced pulmonary hypertension by modulation of autophagy. Ma C, Xu Q, Huang S, Song J, Sun M, Zhang J, Chu G, Zhang B, Bai Y, Zhao X, Wang Z, Li P. FASEB J; 2023 May 01; 37(5):e22906. PubMed ID: 37052859 [Abstract] [Full Text] [Related]
36. Increased MAO-A Activity Promotes Progression of Pulmonary Arterial Hypertension. Sun XQ, Peters EL, Schalij I, Axelsen JB, Andersen S, Kurakula K, Gomez-Puerto MC, Szulcek R, Pan X, da Silva Goncalves Bos D, Schiepers REJ, Andersen A, Goumans MJ, Vonk Noordegraaf A, van der Laarse WJ, de Man FS, Bogaard HJ. Am J Respir Cell Mol Biol; 2021 Mar 01; 64(3):331-343. PubMed ID: 33264068 [Abstract] [Full Text] [Related]
38. Analysis of the microRNA signature driving adaptive right ventricular hypertrophy in an ovine model of congenital heart disease. Kameny RJ, He Y, Zhu T, Gong W, Raff GW, Chapin CJ, Datar SA, Boehme JT, Hata A, Fineman JR. Am J Physiol Heart Circ Physiol; 2018 Oct 01; 315(4):H847-H854. PubMed ID: 29906222 [Abstract] [Full Text] [Related]